RHYTHM PHARMACEUTICALS, INC. Public Float
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Public Float of $3.80 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $3.80B.
- 2024-06-28: Entity Public Float $2.40B.
- 2023-06-30: Entity Public Float $887.00M.
- 2022-06-30: Entity Public Float $188.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.80B 10-K · filed 2026-02-26 |
| 2024-06-28 | $2.40B 10-K · filed 2025-02-28 |
| 2023-06-30 | $887.00M 10-K · filed 2024-02-29 |
| 2022-06-30 | $188.40M 10-K · filed 2023-03-01 |
| 2021-06-30 | $884.40M 10-K · filed 2022-03-01 |
| 2020-06-30 | $828.10M 10-K · filed 2021-03-01 |
| 2019-06-28 | $569.40M 10-K · filed 2020-03-02 |
| 2018-06-29 | $640.80M 10-K · filed 2019-03-08 |
| 2017-06-30 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |